Treatment Recommendations for Dry Cough with Postnasal Drainage
Start with an intranasal corticosteroid spray (e.g., fluticasone or mometasone) for at least one month as first-line therapy for this patient's upper airway-related cough. 1
Initial Management Approach
Given the presentation of dry cough with postnasal drainage, normal vitals, and no shortness of breath, this 64-year-old woman most likely has upper airway cough syndrome (UACS), previously called postnasal drip syndrome. The guidelines are clear that rhinosinusitis and upper airway disease are among the most common causes of chronic cough 1.
First-Line Treatment
- Intranasal corticosteroid spray: Use daily for a minimum of 1 month 1
- This is the guideline-recommended approach when prominent upper airway symptoms are present
- Evidence shows topical nasal steroids given for 2-8 weeks are effective for cough with postnasal drip 1
Important Medication Review
Immediately check if she is taking an ACE inhibitor - if so, discontinue it. The guidelines explicitly state: "No patient with a troublesome cough should continue on ACE inhibitors" 1. This is a common pitfall that must be ruled out first.
If Initial Treatment Fails
The systematic approach requires addressing multiple potential aggravants sequentially 1:
Second-Line: Consider GERD
Even without typical reflux symptoms, gastroesophageal reflux disease (GORD) is a critical consideration. Reflux-associated cough may occur in the absence of gastrointestinal symptoms 1. The guidelines emphasize that "failure to consider GORD as a cause for cough is a common reason for treatment failure" 1.
If upper airway treatment doesn't resolve the cough:
- Start a proton pump inhibitor (omeprazole 20-40 mg twice daily before meals) for a minimum of 3 months 1
- Consider adding a prokinetic agent (metoclopramide 10 mg three times daily) 1
Third-Line: Evaluate for Cough-Variant Asthma
If cough persists despite treating upper airway disease and GERD:
- Consider a 2-week trial of oral corticosteroids to assess for steroid-responsive cough 1
- Cough is unlikely due to eosinophilic airway inflammation if there's no response to this trial 1
Critical Diagnostic Considerations
The guidelines mandate certain baseline evaluations 1:
- Chest radiograph - mandatory to rule out serious pathology
- Spirometry - mandatory baseline assessment
- Detailed occupational and environmental exposure history
When to Pursue Further Investigation
Indications for additional workup include 1:
- Hemoptysis
- Prominent systemic illness
- Suspicion of inhaled foreign body
- Suspicion of lung cancer
- Failure to respond to empirical treatment trials
Common Pitfalls to Avoid
Don't overlook smoking status: If she smokes, smoking cessation is essential as it's one of the commonest causes of persistent cough and is dose-related 1
Don't give up too early: Treatment trials must be adequate in duration - intranasal steroids need at least 1 month, PPIs need at least 3 months 1
Don't assume symptoms correlate with diagnosis: There is poor association between upper airway symptoms and the actual presence of disease causing cough 1. Response to treatment is the pivotal diagnostic factor 2
Antihistamine evidence is mixed: While older guidelines from the US recommended first-generation antihistamine/decongestant combinations 2, the UK Thorax guidelines note "disparity in the reported efficacy of antihistamines" 1. Intranasal corticosteroids have stronger evidence.
Treatment Algorithm Summary
- Verify no ACE inhibitor use (discontinue if present)
- Start intranasal corticosteroid for 1 month minimum
- If no improvement: Add PPI therapy for 3 months minimum
- If still no improvement: Trial oral corticosteroids for 2 weeks
- If refractory: Refer to specialist cough clinic 1
The evidence consistently shows that most cases of troublesome cough reflect an aggravant (upper airway pathology, GERD, asthma, or drugs) in a susceptible individual 1. A systematic, sequential approach to empirical treatment trials is the most cost-effective strategy 1.